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The Pt(II) complex, PtCl2(DIP) (DIP = chelating dinitrogen ligand: 4,7-diphenyl-1,10-phenanthroline), was synthesized and
characterized by elemental analysis (CHN) and 1H NMR and UV-vis techniques. The binding of this complex to calf thymus DNA
was investigated using various physicochemical methods such as spectrophotometric, circular dichroism, spectroﬂuorometric,
melting temperature, and viscosimetric techniques. Upon addition of the complex, important changes were observed in the
characteristic UV-Vis bands (hyperchromism) of calf thymus DNA (CT-DNA): increase in melting temperature, sharp increase
in speciﬁc viscosity of DNA, and induced CD spectral changes. Also the ﬂuorescence spectral characteristics and interaction of Pt
complex with DNA have been studied. Pt bound to DNA showed a marked decrease in the ﬂuorescence intensity. The results show
that both the complex and the NR molecules can intercalate competitively into the DNA double-helix structure. The experimental
results show that the mode of binding of the this complex to DNA is classical intercalation.
1.Introduction
The interaction of transition metal complexes with DNA
has long been the subject of intense investigation in relation
to the development of new reagents for biotechnology
and medicine [1–3]. In these complexes, metal or ligands
can be varied in an easily controlled way to facilitate the
individual applications. There are several types of sites in
the DNA molecule where binding of metal complexes can
occur (i) between two base pairs (intercalation), (ii) in
the minor groove, (iii) in the major groove, and (iv) on
the outside of the helix [4]. The observation that neutral
platinum coordination compounds inhibit division and cell
growth has generated much interest in the potential value
of inorganic drugs in the ﬁeld of cancer chemotherapy [5–
10]. Cisplatin has been shown to have potent antitumor
activityandisnowadaysroutinelyemployedinthetreatment
of several cancers [11–21]. However, because of its severe
side eﬀects a need for new platinum complexes has arisen,
and several new derivatives have been synthesized and
tested against various tumor model systems, with the hope
of discovering new drugs with improved properties [9].
In the most successful second-generation cisplatin analogs
(i.e., carboplatin), the chloride ligands have been replaced
by a carboxylate. This structural variation in carboplatin
seems to be responsible for the reduced toxicity of this
compound [18, 19, 22]. In this paper, the Pt(II) com-
plex, PtCl2(DIP) (DIP = chelating dinitrogen ligand: 4,7-
diphenyl-1,10 phenanthroline) (Figure 1), was synthesized
and characterized by spectroscopic (1H,13C NMR) and
elemental analysis techniques. Binding interactions of this
complex with calf thymus (CT) DNA have been investigated
by UV absorption spectrophotometry, circular dichroism
spectropolarimetry, melting temperature, and viscosimetry
methods.
2.MaterialsandMethods
2.1. Material. Commercially pure chemicals, such as 4,7-
diphenyl-1,10 phenanthroline (Merck), Neutral Red (Third
Reagent Factory, Shanghai), Tris-HCl (Sigma Co., Madrid
Spain), were used as purchased. Experiments were car-
ried out in Tris-HCl buﬀer (10mM, pH 7.2). Solution2 Bioinorganic Chemistry and Applications
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Figure 1: Schematic structure of PtCl2(DIP) (DIP = chelating
dinitrogen ligand: 4,7-diphenyl-1,10 phenanthroline).
was prepared with distilled water. Highly polymerized calf
thymus DNA (CT-DNA) was purchased from Sigma Co.
[PtCl2(DMSO)2]( D M S O= dimethyl sulfoxide) was pre-
pared as already described [23].
The stock solution of DNA was prepared by dissolving of
DNA in 10mM of the Tris-HCl buﬀer at pH 7.2. A solution
ofCT-DNAgavearatioofUVabsorbanceat260and280nm
morethan1.8,indicatingthatDNAwassuﬃcientlyfreefrom
protein.
The DNA concentration (monomer units) of the stock
solution was determined by UV spectrophotometery, in
proerly diluted samples, using the molar absorption coeﬃ-
cient 6600M−1cm−1 at 260nm [24]. The stock solution was
stored at 4◦C.
To study the platinum complex interaction with DNA,
stock solutions were prepared by dissolving the complex in
theTris-HClbuﬀerusedinthisstudytoaﬁnalconcentration
of0.5mg·mL−1 andincubatedfor24hat37◦Cafteraddition
of DNA.
2.2. Synthesis of PtCl2(DIP). The appropriate amount of
diphenylphenanthrolineligand(DIP)(1mmol)inmethanol
(5mL) was added dropwise to a stirred solution of [PtC12
(DMSO)] (1mmol) in the same solvent (30mL). After 12h
of stirring the light red solid was collected, washed with
methanol and diethyl ether, and dried in air. Yeild 83%.Anal.
Calc.f o rC 24H16N2Cl2Pt: C, 48.0; H, 2.67; N, 4.67. Found: C,
48.5; H, 2.9; N, 4.5. 1H NMR of the complex: δ = 8.54 (d,
2 H atoms of phen ligand), δ = 8.06 (d, 2H atoms of phen
ligand), δ = 7.83 (d, 2H atoms of phen ligand), δ = 7.28
(m, 10 H atoms of phenyl groups). 1H NMR of the DIP
ligand: δ = 9.29 (d, 2 H atoms of phen ligand), δ = 7.79
(d, 2H atoms of phen ligand), δ = 7.57 (d, 2H atoms of phen
ligand),δ = 7.55(m,10Hatomsofphenylgroups).Inthe 1H
NMR spectrum of Pt(DIP)Cl2 the signals due to the various
protons of 4,7-diphenyl-1,10 phenanthroline ligand are seen
to be shifted with corresponding free ligand and suggesting
complexation.
2.3. Methods. The complex obtained was characterized by
elemental analysis, UV-Vis, and 1H NMR spectroscopy. The
elemental analysis was performed using a Heraeus CHN
elemental analysis. The 1H NMR spectra were recorded
withaBrukerAvanceDPX200MHz(4.7Tesla)spectrometer
using CDCl3 as solvent and sodium 3-(trimethylsilyl)tet-
radeuteriopropionate as internal standard.
Absorbance spectra were recorded using an hp spectro-
photometer (Agilent 8453). Circular dichroism (CD) mea-
surements were recorded on a JASCO (J-810) spectro-
polarimeter. Solutions of DNA and platinum, which were
prepared as described previously, were scanned in 0.5cm
( 1m L )q u a r t zc u v e t t e .T h es p e c t r aw e r er e c o r d e da f t e ri n -
cubation at 37◦C for 24h. For viscosity measurements, a
viscosimeter (SCHOT AVS 450) which thermostated at 25◦C
by a constant temperature bath was used. Flow time was
measured with a digital stopwatch; the mean values of three
replicated measurements were used to evaluate the viscosity
´ η of the samples. The data were reported as (η/η◦)
1/3 versus
1/R that R = [DNA]/[PtCl2(DIP)] ratio [25], where η◦ is
the viscosity of the DNA solution alone. For DNA melting
studies, we used a Cary (UV 100 Bio) spectrophotometer
equippedwithatemperaturecontroller(COMPLEXPTS100
Bio) and the temperature of the cell holder was changed as:
35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, and 90◦C.
All ﬂuorescence measurements were carried out with a
JASCO spectroﬂuorometer (FP6200).
3. Results and Discussion
3.1. Electronic Spectra. Electronic absorption spectra are in-
itially employed to study the binding of complexes to DNA.
In the present study, the interaction of Pt (II) complex
with CT-DNA has been monitored in aqueous solution.
Aliquots of the DNA solution at a constant concentration
equal to 5 × 10
−5 incubated with Pt complex at ri values
of 0.1–0.7 in 10mM Tris-HCl buﬀer, (pH 7.2) at 37◦C.
The ri values were calculated from the following equation:
ri = [complex]/[DNA]. The UV band of DNA at about
260nm was monitored at the absence and presence of
diﬀerent amounts of Pt (II) complex. “Hyperchromic” eﬀect
and “hypochromic” eﬀect are the spectra features of DNA
concerning its double-helical structure [26]. The spectral
change process reﬂects the corresponding changes in DNA
in its conformation and structures after the drug bound to
DNA. Hypochromism results from the contraction of DNA
in the helix axis, as well as from the change in conformation
on DNA; in contrast, hyperchromism derives from damage
to the DNA double-helix structure [27, 28]. In contrast, as
shown in Figure 2, the absorption spectra of DNA increase
with increasing complex concentration. This is a typical
“hyperchromic” eﬀect which suggests that the DNA double-
helix structure is damaged after the complex bound to DNA
through intercalation mode.
3.2. Thermal Denaturation Experiments. The consequences
of adduct formation on the stability of the double helix
in CT-DNA were assayed by recording the DNA melting
proﬁles. Thermal behavior of DNA in the presence of
complexescangiveinsightintotheirconformationalchangesBioinorganic Chemistry and Applications 3
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Figure 2: Absorption spectra of (a) DNA (5 × 10
−5 M) in the
absence (strong line) and presence of increasing amounts of Pt
complex: ri = [Complex]/[DNA] = 0.0, 0.1, 0.3, 0.5, 0.7.
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Figure 3: Melting curves of CT-DNA (5 × 10
−5 M) in the absence
and in the presence of Pt complex at various ri = [Complex]/[DNA]
= 0.0, 0.1, 0.2, 0.4 in Tris-HCl (10mM), pH = 7.2.
when temperature is raised and oﬀer information about
the interaction strength of complexes with DNA. The
stabilization of CT-DNA through the hydrogen-bonding and
electrostatic interactions of the noncovalent complexes was
further assessed by measuring the melting temperature. We
measured the changes in the absorbance at 260nm as a func-
tion of temperature for calf thymus DNA in the absence and
presence of complex. Our experiments were carried out for
CT-DNA in the absence and presence of diﬀerent amounts
of platinum complex. The denaturation temperatures were
increased for the ratio of complex to DNA (ri =0, 0.1, 0.2,
and0.4,resp.;Figure 3).Thedenaturationtemperatureswere
increased as 67, 70, 75, and 84.5◦Cf o rt h er a t i oo fc o m p l e x
to DNA (ri =0, 0.1, 0.2 and 0.4, resp.).These results are due
to the stabilization of the DNA helix in the presence of
intercalative complex. This stabilizing action of complex is
very similar to that of previously observed for daunomycin
[29], cryptolepine [30] and Chlorobenzylidene [31]. This
provides another support for the intercalation of complex
into the DNA double helix.
3.3. Circular Dichroism. Circular dichroism (CD) spectro-
scopyisaveryusefulmethodtoanalyzethestructureofopti-
cally active materials such as proteins and DNA; therefore,
the CD technique was used to determine the DNA confor-
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Figure 4: Circular dichroism spectra of CT-DNA (5 × 10
−5 M)
in Tris-HCl (10mM), in the presence of increasing amounts of
Pt complex at the following stoichiometric ratios: ri = [com-
plex]/[DNA] = 0.0, 0.05, 0.15, 0.25.
mational changes induced by complex pt. It should be noted
that the titled platinum (II) complex is optically inactive and
hence dose not exhibit any CD spectra. CD spectra were
measured at various ratios of the complex to DNA. The
observed CD spectrum of calf thymus DNA consists of a
positive band at 275nm due to base stacking and a negative
band at 245nm due to helicity, which is characteristic of
DNA in right-handed B form, in the ultraviolet region [32].
The results of CD studies indicated that by increasing of
[complex]/[DNA] ratio, clear changes occurred in the CD
spectraofB-DNA(Figure 4).Theintensitiesofnegativeband
decreased (shifting to zero levels) along with a bathochromic
eﬀect (Red Shift) about 4.0nm, while the positive bands
increased signiﬁcantly without any changes in their wave-
length(Figure 4).SimilarchangesinCDspectrawithvarious
interpretations have been reported. For example, some
investigators believed that this type of changes in the CD
spectra may be reﬂected of a shift from a B-like DNA
structure toward one with some contributions from an A-
like conformation [33, 34], but this phenomenon could be
due to groove binding that stabilizes the right-handed B
form of DNA [35]. This enhancement of the CD band of
DNA at 275nm is due to distortions induced in the DNA
structure [36]. We think the increasing of CD signal around
275nm along with increasing of platinum complex is an
important evidence for the intercalation of the complex with
the base pairs, which concurs with the data reported by other
researchers [37, 38] and also conﬁrms our other evidences.
In addition, red shift of the CD spectra at 245nm suggests
that there exists interaction between aromatic rings of the
complex and base pairs of DNA [37]. Also, molar ellipticity
values were calculated according to the formula [39]:
[θ]λ =
100θ(λ)
lC
,( 1 )
where [θ]λ is the molar ellipticity value at a particular wave-
length expressed in degcm2 dmol−1, C the concentration in
moles of nucleotide phosphate per liter, l the length of the
cell in dm, and θλ is the observed rotation in degrees (◦). The
results are summarized in Table 1.4 Bioinorganic Chemistry and Applications
Table 1: Eﬀe c t so fP tc o m p l e xo nt h eC Ds p e c t r ao fD N A ,i nt r i s
HCL buﬀer.
θ245nm θ275nm
−80444 55752
−81110 616084
−62994 78404
−62343 86919
3.4. Viscosity Measurements. As a means for further explor-
ing the binding of the complex to DNA, viscosity measure-
ments were carried out by varying the concentration of the
added complex to DNA solution. The values of relative spe-
ciﬁc viscosity (η/η0)
1/3 versus 1/R (R = [DNA]/[complex])
in the absence and in the presence of complex in tris HCL
buﬀers, were plotted (Figure 5). Figure 5 shows that the
speciﬁc viscosity of the DNA sample clearly increases with
the addition of the complex. The viscosity studies provide
a strong argument for intercalation [40]. It is known that
the groove binder like Hoechst 33258 does not cause an
increase in the axial length of the DNA and therefore did
not alter the relative viscosity. In contrast, cisplatin which is
known to kink DNA through covalent binding, shortening
the axial length of the double helix, caused a decrease in
the relative viscosity of the solution. Partial intercalators
also reduce the axial length observed as a reduction in
relative viscosity, whereas the classical organic intercalators
such as ethidium bromide increased the axial length of the
DNA and it becomes more rigid resulting in an increase
in the relative viscosity [41]. Results conﬁrm the sensitivity
of viscosity measurements to the diﬀerent modes of DNA
binding. In this paper, it was observed that increasing the
platinum complex concentration leaded to an increase of the
DNA viscosity. Thus, we may deduce that the [PtCl2(DIP)]
complex, certainly is a DNA intercalator. In essence, the
length of the linear piece of B-form DNA is given by the
thickness of the base pairs that are stacked along the helix
axis in van der Waals contact with each other. Introducing
another aromatic molecule into the stack therefore increases
the length. So, we think the viscosity increase of the DNA
caused by the addition of the complex can provide further
support for the intercalative mode of binding. Since the
interaction of this platinum (II) complex with DNA can
make DNA longer, we would expect that the relative viscosity
of DNA increases with a slope between 0 and 0.96 (a value
measured for ethidium bromide [42]) if the intercalation of
the Pt(II) complex was either only one interaction mode
or much stronger than other interaction(s). But, in this
study, the relative viscosity of DNA increase with a slope
of 0.71 (Figure 5) and it is reasonably believed that may be
other interaction(s) between DNA and the Pt(II) complex
occurred and is reasonable for the decrease of the slope.
These results clearly show that the importance of using
several techniques to ascertain intercalation.
3.5. Fluorescence Studies. The excitation wavelength at
280nm was used for the ﬂuorescence measurements and the
emission spectra were recorded between 300 and 500nm.
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Figure 5: Eﬀect of increasing amounts of complex on the viscosity
of CT-DNA (5 ×10
−5 M) in Tris-HCl (10mM).
The excitation and emission slits were both 10nm, and
the scan speed was 200nmmin−1. Fluorescence titration
experiments were performed by keeping the complex con-
centration constant and stoichiometrically varying the DNA
concentration. Each spectrum was scanned for three times
to acquire the ﬁnal ﬂuorescence emission spectra. Our
results (Figure 6) show that in presence of excess of DNA
the ﬂuorescence intensity was completely quenched. This
indicatedthatallfractionsofthebinding sitesofthecomplex
interacted with DNA. Stern-Volmer plots for DNA quench-
ing were obtained by using the Stern-Volmer equation:
F0
F
= 1+Kq[Q],( 2 )
where F0 = ﬂuorescence intensity of ﬂuorophore in absence
of quencher; F = ﬂuorescence intensity of ﬂuorophore in
presence of quencher; Kq = Stern-Volmer constant; [Q] =
quencher concentration. However, the Stern-Volmer plots
for quenching of the ﬂuorescence intensity by DNA deviate
from linearity at quencher concentrations larger than 1.0 ×
10
−5 M. In addition, by increasing the temperature, the
ﬂuorescence intensity of the complex increased whether
there was DNA in the solution or not, and the Kq decreased
with the temperature rising. These results indicate that the
probable quenching mechanism of ﬂuorescence by DNA
is a static quenching procedure [43], that is, a complex
was formed between the DNA base pairs and the complex.
Because it was the static quenching, the quenching constant
wasconsideredastheformationconstantofthecomplexand
DNA [44, 45].
3.5.1. Thermodynamic Measurements. To obtain a detailed
view of the interaction between the platinum complex and
DNA, a powerful approach is to parse the free energy of the
binding reaction into its component terms. The four classes
ofnoncovalentinteractionsthatcanplayaroleinthebindingBioinorganic Chemistry and Applications 5
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Figure 6: Eﬀect of DNA on the ﬂuorescence spectra of Pt complex
(8.34×10
−5 M)inTris-HCl(10mM)buﬀer. ri =[DNA]/[Complex]
= 0.0, 0.2, 0.6, 0.8, 1, 1.2.
of drug molecules to biomolecules are hydrogen bonds, van
der Waals forces, electrostatic interactions, and hydrophobic
bond interactions.
In the intercalation process, a planar aromatic chro-
mophore is inserted between two adjacent base pairs in
a DNA helix. Alternatively, in minor groove binding, an
isohelical drug molecule binds in the minor groove of
DNA without inducing signiﬁcant structural changes in the
DNA [46]. While the complex formed from intercalation is
stabilized by hydrophobic interactions and van der Waals
forces, the complex formed from minor groove binding is
stabilized mainly by hydrophobic interactions [46].
Consequently, in this study, the formation constant
for complex-DNA adduct formation is evaluated at four
diﬀerent temperatures (277, 27, 298, 310) allowing for
the determination of thermodynamic parameters such as
enthalpy (ΔH)a n de n t r o p y( ΔS) by the Van’t Hoﬀ equa-
tion. Binding constant (Kf) values were obtained from
experimental results at four diﬀerent temperatures. The
thermodynamicparametersΔSandΔH werecalculatedfrom
these binding constants. Ross and coworkers [47]r e p o r t e d
that when ΔH<0o rΔH ≈ 0a n dΔS>0, the electrostatic
force dominates the interaction; when ΔH<0a n dΔS<0,
van der Waals interactions or hydrogen bonds dominate the
reaction; and when ΔH>0a n dΔS>0, hydrophobic
interactions dominate the binding process. The positive
slope in the Van’t Hoﬀ plot indicates that the reaction of
DNA with the complex is exothermic and enthalpy favored.
The ΔH and ΔS values of the complex-DNA adduct were
−64.12kJ/mol and −127.74J/mol, respectively. From the
thermodynamic data, it is quite clear that while complex
formation is enthalpy favored, it is also entropy disfavored.
Formationofthecomplexthereforeresultsinamoreordered
state, possibly due to the freezing (ﬁxing) of the motional
freedom of both the complex and DNA molecules. In
conclusion, entropy and enthalpy changes are conﬁrmed the
intercalation mode of binding.
InordertoinvestigatethemodeofPtcomplexbindingto
DNA, Neutral Red (NR) has been employed in examination
of the reaction, as NR presumably binds initially to DNA
by intercalation. Neutral Red is a planar phenazine dye, and
in general, is structurally similar to other planar dyes, for
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Figure 7: Eﬀect of Pt complex on ﬂuorescence spectra of NR-DNA.
cDNA = 7.74 × 10
−5 M; cNR = 1.00 × 10
−5 M; and c Pt complex
= 0.00, 0.25, 0.5, 0.75, 1.00, and 2.00 × 10
−5 M for curves 1–6,
respectively.
example, those of the acridine, thiazine, and xanthene kind.
In recent years, the interaction of the ﬂuorescent NR dye
with DNA has been demonstrated by spectrophotometric
[48] and electrochemical [49] techniques. Compared with
a common ﬂuorimetric probe, ethidium bromide (EB) [50,
51], the NR dye oﬀers lower toxicity, higher stability and
convenience of use [52]. In addition, its solution remains
stable for up to 2 years. ﬂuorescent spectra collected from a
solution of ﬁxed [NR] and diﬀerent [DNA] concentrations.
Thus, NR can be used to probe the interaction of small
molecules with DNA. With the addition of Pt complex to
a solution of NR-DNA, some NR molecules were released
into solution after an exchange with the Pt complex, and
this resulted in ﬂuorescence quenching (Figure 7). This
supported the view that the complex intercalated into the
DNA [53].
4. Conclusion
The new platinum (II) complex exhibits a high binding
aﬃnity for CT-DNA. Diﬀerent instrumental methods were
used to investigate the interaction mechanism. The results
support the notion that the complex can bind to CT-DNA by
intercalation. The absorption spectrum of the DNA shows
a large degree of hyperchromism develops in the spectrum.
Hyperchromism is usually characteristic of interactions
between DNA and the complex and arises from the strong
stacking interaction between the aromatic chromophore
and the base pairs. The ﬂuorescence studies showed an
appreciable decrease in the emission upon addition of DNA.
The positive slope in the Van’t Hoﬀ plot indicates that
the reaction between the complex and DNA was enthalpy-
favored (ΔH =− 64.12kJ/mol). CD results showed deep
conformational changes in the CT-DNA double helix upon
binding with the complex. The increase in the relative
viscosity as well as melting temperature of CT-DNA in the
presence of the complex shows that intercalation must be the
predominant form of binding.6 Bioinorganic Chemistry and Applications
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